Results

Total Results: 721 records

Showing results for "drug".

461. JAMA JATS (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/UA7cEG8wH4xh8-fr7Lfw9q
     September 18, 2018 - The US Food and Drug Administration considers a weight loss of 5% as clini- cally important.1 Most of … review of pharmacotherapy-based trials focused on trials that used dosages approved by the US Food and Drug … study participants.1 Meta-analyses could not be conducted because of the few number of trials for each drug

462. Archived: Evidence Summary: Chlamydia and Gonorrhea: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary3/chlamydia-and-gonorrhea-screening-september-2014
     September 23, 2014 - Food and Drug Administration for current clinical practice were included to determine diagnostic accuracy … Food and Drug Administration (FDA) and are available for clinical practice in the United States. … Food and Drug Administration; GC = gonorrhea/chlamydia; NG = Neisseria gonorrhoeae .

463. Archived: Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/intimate-partner-violence-and-abuse-of-elderly-and-vulnerable-adults-screening-october-2018
     October 23, 2018 - depression in adolescents, adults, and pregnant women; screening for alcohol misuse; and screening for drug … adolescents, 35 adults, and pregnant women; 36 screening for alcohol misuse; 37 and screening for drug … Screening for Illicit Drug Use: U.S. Preventive Services Task Force Recommendation Statement.

464. Recommendation: Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/healthy-diet-and-physical-activity-counseling-adults-with-high-risk-of-cvd
     November 24, 2020 - trans fats, and added sugars, as recommended by the US Department of Agriculture and the US Food and Drug … counseling interventions to promote a healthy diet and physical activity (consistent with US Food and Drug

465. Archived: Syphilis Infection in Nonpregnant Adults and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/syphilis-infection-in-nonpregnant-adults-and-adolescents-june-2016
     June 07, 2016 - in persons who have a preexisting condition (ie, collagen vascular disease, pregnancy, intravenous drug … Harms of treatment include rare adverse drug-related effects, such as anaphylaxis due to penicillin allergy

466. Fdqhj57Mmfqognvjn Qg9Q (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/fdQHJ57mMFqognVJn_qg9q
     May 23, 2019 - The AAP also recommends that physicians discuss the hazards of alcohol and other drug use with parents

467. untitled (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/y_ApQN4Tw4RtnoWWrofH8d
     December 20, 2016 - most widely used, currently available serologic screening test for HSV-2 approved by the US Food and Drug … the most widely available sero- logic test for genital HSV-2 infection approved by the US Food and Drug

468. Evidence Summary: Colorectal Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary19/colorectal-cancer-screening
     May 18, 2021 - US Food and Drug Administration. Published 2014. Accessed August 1, 2019. … SSP, sessile serrated polyp. a Screening technology with conditional approval from the US Food and Drug … , smoking status, physical activity, diet, vitamin use, aspirin use, nonsteroidal anti-inflammatory drug … use, cholesterol-lowering drug use, hormone replacement therapy. d Standardized 8-year risk. e One … Abbreviations: CRC, colorectal cancer; CT, computed tomography; ECF, extracolonic finding; FDA, US Food and Drug

469. Screening for Osteoporosis to Prevent Fractures: A Systematic Evidence Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/R_cAa3AjFGQ2np_aQnzQGA
     February 11, 2025 - For KQ4 and KQ5, RCTs or controlled cohort studies (for harms only) evaluating US Food and Drug Administration … see the USPSTF Procedure Manual.2 DXA indicates dual-energy x-ray absorptiometry; FDA, US Food and Drug … Results of Randomized, Placebo-Controlled Trials of Treatment for Osteoporosis (KQ4 and KQ5) Favors drug … The comparative effectiveness and harms of alternative pharmacotherapies and drug holidays was not evaluated

470. Screening for Obesity in Children and Adolescents: Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/DMDPeSf_nEUM-HrVrX6c7U
     June 20, 2017 - Metformin has been used for weight loss in children but is not approved by the US Food and Drug Administration … Orlistat is approved by the US Food and Drug Administration for use in adolescents 12 years and older … Rise in antiobesity drug prescribing for children and adolescents in the UK: a population-based study

471. Screening for Hepatitis C Virus Infection in Adolescents and Adults: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/WEqCV3NvnZAeLdC_pp6nVK
     October 01, 2018 - Ten deaths occurred in 3 studies of per- sons reporting recent injection drug use or use of opioid substitu … Four studies evaluated DAA regimens approved by the US Food and Drug Administration (FDA) for use in … Infect Drug Resist. 2018;11: 295-298. doi:10.2147/IDR.S153060 22. … Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use … Int J Drug Policy. 2018;62:94-103. doi:10. 1016/j.drugpo.2018.10.004 33.

472. Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/2GDCmTe7akyrAHsTMbfz72
     May 06, 2022 - Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Evidence Report and Systematic Review for the USPSTF Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer Updated Evidence Report and Systematic Review for the US Preventive Services Task Force Janelle M. Guirguis-Blake, MD; C…

473. Archived: Evidence Summary: Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary25/screening-for-abnormal-blood-glucose-and-type-2-diabetes-october-2015
     April 13, 2015 - It also found that lifestyle and drug interventions for impaired fasting glucose (IFG) or impaired glucose … For rare events (incidence <1%), we calculated the Peto odds ratio. 31 We stratified results by drug … outcomes and were limited to 3-y follow-up with few events; evidence often limited to a single study per drug … Arrows from these boxes represent drug and/or lifestyle interventions on the following health outcomes … Intensive management, including lifestyle advice, aspirin, drug treatment of blood glucose, blood pressure

474. Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for CVD Prevention in Adults With Cardiovascular Risk Factors: USPSTF Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/oo3XPmknWkhsBbAuYZQyQw
     November 24, 2020 - trans fats, and added sugars, as recommended by the US Department of Agriculture and the US Food and Drug … counseling interventions to promote a healthy diet and physical activity (consistent with US Food and Drug

475. Screening for Anxiety in Children and Adolescents: Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/oZSntFpszryu7mAnjdhkrw
     September 05, 2023 - screening; diagnostic test accuracy studies; RCTs of cognitive behavioral therapy (CBT) or US Food and Drug … Eligible pharmacotherapy interventions included agents ap- proved by the US Food and Drug Administration … Third, the review was limited to CBT and drugs ap- proved for pediatric use by the US Food and Drug Administration

476. Screening for Syphilis Infection in Nonpregnant Adults: U.S. Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/VhSwc46MPwjDPNsgVrVm-B
     June 07, 2016 - persons who have a preexist- ing condition (ie, collagen vascular disease, pregnancy, intrave- nous drug … Harms of treat- ment include rare adverse drug-related effects, such as anaphy- laxis due to penicillin

477. Txncztmvpe5Ftseqts6Obm (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/TxnCztmvpE5FtsEqts6oBM
     November 01, 2015 - Food and Drug Administration. More research on the accuracy of kiosk measurements is needed. … - nosed with hypertension and could subsequently expe- rience the more serious harms of unnecessary drug

478. untitled (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/QWUmLEKdwcYA-AKGp5dNaQ
     August 09, 2016 - ticipants reached the target LDL-C level of 110 mg/dL or less, with greater effects at higher doses.1 One drug

479. Archived: Final Evidence Summary: Folic Acid to Prevent Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary25/folic-acid-to-prevent-neural-tube-defects-preventive-medication-2009
     May 15, 2009 - education, gravidity, month that prenatal care began, previous NTD, body mass index, smoking, alcohol use, drug

480. Screening for Hepatitis B Virus Infection in Pregnancy: Reaffirmation Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ykFSVS29KAwKzFWSXAVoMY
     June 01, 2009 - with unknown HBsAg status or with new or continuing risk factors for HBV infection (such as injection drug